Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-004628·BELITE BIO, INC
Schedule 13G ownership disclosure
BELITE BIO INC
Ordinary shares, par value US$0.0001 per share · CUSIP: 07782B104
Event date: 2024-12-31
- Filing-level shares
- 17,095,263.00
- Percent of class
- 53.7%
- Lin Bioscience International Ltd.
Shares: 17,095,263.00 · Class: 53.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-004628
- Form type
- SCHEDULE 13G
- Filer
- BELITE BIO, INC
- CIK
- CIK 1889109
- Filed
- Jan 21, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership